Pacific Edge poised for US$1.2 billion opportunity

Pacific Edge poised for US$1.2 billion opportunity
Brent Melville
Chris Gallaher, chair of Pacific Edge, described the six months through September as a step-change for the firm, when revenue grew and losses narrowed as the cancer diagnostics company scales up to meet burgeoning US and global demand for its cancer detection testing.That included a two-month contribution from the US Centers for Medicare and Medicaid Services - CMS - including the Cxbladder for local coverage, which saw operating revenue in that market jump 46 percent to $2.9 million from the same period a year earlier.CMS-related testing acros...

More Services

Creative solutions needed to keep NZ workers
Economy

Creative solutions needed to keep NZ workers

Robert Walters sees talent migration potentially getting worse in 2025.

‘Battle-hardened’ Trade Window eyes growth
Markets

‘Battle-hardened’ Trade Window eyes growth

The customs software minnow has weathered the storm. What next?

Pattrick Smellie 21 Nov 2024
Crimson big enough for ASX IPO: Beaton
Finance

Crimson big enough for ASX IPO: Beaton

A US market listing at a greater scale looks more likely.

Pattrick Smellie 06 Nov 2024
CoreLogic data suggests property market floor is nigh
Property

CoreLogic data suggests property market floor is nigh

Broad economic trends underpin the latest figures, CoreLogic's economist says.